As rare disease trials face persistent feasibility challenges, Bayesian designs are gaining momentum by enabling more ...

The integration of artificial intelligence (AI) and machine learning (ML) in oncology clinical trials is rapidly evolving alongside the broader field. For example, AI-driven adaptive trial designs may ...

Prognostic Impact of Prostate-Specific Antigen at 6 Months After Radiotherapy in Localized Prostate Cancer: An Individual Patient Data Analysis of Randomized Trials National estimates of cancer ...

In this final review in the series on wearable DHTs, we highlight important challenges that must be met to integrate the devices into clinical guidelines and practice. We have deliberately grounded ...

BioNTech will present significant clinical trial data at the prestigious ASCO Annual Meeting, highlighting the advancement of its diversified oncology portfolio. The preliminary results for BNT327 and ...